BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 24002160)

  • 1. Natural ingredients for darker skin types: growing options for hyperpigmentation.
    Alexis AF; Blackcloud P
    J Drugs Dermatol; 2013 Sep; 12(9 Suppl):s123-7. PubMed ID: 24002160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin lightening preparations and the hydroquinone controversy.
    Draelos ZD
    Dermatol Ther; 2007; 20(5):308-13. PubMed ID: 18045355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of melanin synthesis, activation and distribution pathway by a nonprescription natural regimen is equally effective to a multiple prescription-based therapeutic regimen.
    Thornfeldt C; Rizer RL; Trookman NS
    J Drugs Dermatol; 2013 Dec; 12(12):1449-54. PubMed ID: 24301247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kojic Acid for Melasma: Popular Ingredient in Skincare Products.
    Zachary CM; Wang JV; Saedi N
    Skinmed; 2020; 18(5):271-273. PubMed ID: 33160435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The top 10 cosmeceuticals for facial hyperpigmentation.
    Searle T; Al-Niaimi F; Ali FR
    Dermatol Ther; 2020 Nov; 33(6):e14095. PubMed ID: 32720446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural options for the management of hyperpigmentation.
    Leyden JJ; Shergill B; Micali G; Downie J; Wallo W
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1140-5. PubMed ID: 21623927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical treatments for melasma and postinflammatory hyperpigmentation.
    Lynde CB; Kraft JN; Lynde CW
    Skin Therapy Lett; 2006 Nov; 11(9):1-6. PubMed ID: 17075653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The melanogenesis and mechanisms of skin-lightening agents--existing and new approaches.
    Gillbro JM; Olsson MJ
    Int J Cosmet Sci; 2011 Jun; 33(3):210-21. PubMed ID: 21265866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single blind, randomized, controlled trial of a lightening product with and without iontophoresis versus tretinoin and vehicle for hyperpigmentation.
    Wanner M; Houston N; Javorsky E; Yuan M; Alora-Palli M; Kimball AB
    J Drugs Dermatol; 2015 Jan; 14(1):13-8. PubMed ID: 25607903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
    Callender VD; St Surin-Lord S; Davis EC; Maclin M
    Am J Clin Dermatol; 2011 Apr; 12(2):87-99. PubMed ID: 21348540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing patient care with "natural" products: treatment of hyperpigmentation.
    Woolery-Lloyd H; Friedman A
    J Drugs Dermatol; 2009 Jun; 8(6 Suppl):s10-3. PubMed ID: 19562884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facial skin-lightening benefits of the tetrapeptide Pro-Lys-Glu-Lys on subjects with skin types V-VI living in South Africa.
    Farwick M; Maczkiewitz U; Lersch P; Summers B; Rawlings AV
    J Cosmet Dermatol; 2011 Sep; 10(3):217-23. PubMed ID: 21896134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hyperpigmentation in darker racial ethnic groups.
    Grimes PE
    Semin Cutan Med Surg; 2009 Jun; 28(2):77-85. PubMed ID: 19608057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovations in natural ingredients and their use in skin care.
    Fowler JF; Woolery-Lloyd H; Waldorf H; Saini R
    J Drugs Dermatol; 2010 Jun; 9(6 Suppl):S72-81; quiz s82-3. PubMed ID: 20626172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight into skin lightening cosmeceuticals for women of color.
    Badreshia-Bansal S; Draelos ZD
    J Drugs Dermatol; 2007 Jan; 6(1):32-9. PubMed ID: 17373159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural considerations for skin of color.
    Baumann L; Rodriguez D; Taylor SC; Wu J
    Cutis; 2006 Dec; 78(6 Suppl):2-19. PubMed ID: 17354519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound enhanced skin-lightening effect of vitamin C and niacinamide.
    Hakozaki T; Takiwaki H; Miyamoto K; Sato Y; Arase S
    Skin Res Technol; 2006 May; 12(2):105-13. PubMed ID: 16626384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hyperpigmentation.
    Rossi AM; Perez MI
    Facial Plast Surg Clin North Am; 2011 May; 19(2):313-24. PubMed ID: 21763992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermocosmetic management of hyperpigmentations.
    Guerrero D
    Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S166-9. PubMed ID: 23522633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation using vitamin C with a full-face iontophoresis mask and a mandelic/malic acid skin care regimen.
    Taylor MB; Yanaki JS; Draper DO; Shurtz JC; Coglianese M
    J Drugs Dermatol; 2013 Jan; 12(1):45-50. PubMed ID: 23377327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.